Complete OSRH Stock Valuation Analysis

Comprehensive intrinsic value analysis using 2 different methodologies

OSRH Peer Valuation Analysis

Relative valuation based on comparable company trading multiples

Peer Valuation Analysis

Fair Value Range Analysis

Based on median multiples from 7 peer companies in Healthcare

P/E Ratio
$0.00
-100.0%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.00
-100.0%
Peer Median: 2.5x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for OSRH's business model and current situation.
Multiple Comparison
MultipleOSRH CurrentPeer MedianPeer AveragePremium/DiscountAssessment
P/E Ratio-1.3x0.0x0.0x-Infinity%
Undervalued
EV/EBITDA174.0x0.0x0.0xInfinity%
Overvalued
P/S RatioInfinityx2.5x2.3xInfinity%
Overvalued
Peer Companies
Click any company to view their valuation
CompanyMarket CapP/E RatioEV/EBITDAP/S Ratio
$0.03B0.0x0.0x60.8x
$0.03B0.0x0.0x2.5x
$0.03B0.0x0.0x0.0x
$0.02B0.0x0.0x23.5x
$0.03B206.2x143.3x0.0x
$0.03B0.0x0.0x0.0x
$0.02B0.0x0.0x2.2x

OSRH Earnings Power Value (EPV)

Normalized earnings-based valuation for sustainable earning power assessment

Earnings Normalization
Earnings ComponentAmount ($B)Description
Reported Earnings-0.0Base earnings from financial statements
Normalized Earnings-0.0Final normalized earning power

One-time Items: Remove non-recurring gains/losses

Cyclical Adjustment: Normalize for economic cycle position

EPV Result
$-15.60
EPV per Share
$1.40
Current Price
-1214.4%
Upside/Downside
6.7%
WACC: 6.7% (calculated from market data)
Confidence: High
Normalized earnings approach
EPV Calculation Breakdown

Enterprise Value Calculation

Normalized Earnings$-0.0B
Cost of Capital6.7%
Enterprise Value$-0.0B

Per Share Value

Enterprise Value$-0.0B
Shares Outstanding0.0B
EPV per Share$-15.60

WACC Components

Cost of Equity9.2%
After-Tax Cost of Debt3.5%
Equity Weight55.9%
Debt Weight44.1%
WACC6.7%